UNTIL CANCER IS CURED
DEAD

Serial Number

90461300

Owner

INSTIL BIO INC.

Attorney

Richard Y. Kim

Filing Date

Jan 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

UNTIL CANCER IS CURED Trademark

Serial Number: 90461300

UNTIL CANCER IS CURED is a trademark filed by INSTIL BIO INC. on January 12, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

INSTIL BIO INC. (13 trademarks)

3963 Maple Avenue, Suite 350
DALLAS, TX 75219

Entity Type: 03

Trademark Details

Filing Date

January 12, 2021

Registration Date

Not Registered

Published for Opposition

January 11, 2022

Goods & Services

Providing transportation services of patient tumor samples and biomedical services and methods, namely, the storage of the patient tumor samples for medical use of the patient tumor samples for tissue digestion and cell isolation and expansion, amplification, stimulation and cell growth, and human cells for medical use and storage, and cell population expansion and stimulation, and solid tumor tissue digestion and white blood cell and lymphocyte isolation and white blood cell and lymphocyte storage and white blood cell and lymphocyte expansion and amplification and white blood cell and lymphocyte growth and stimulation; providing medical transport services and biomedical services and methods, namely, the storage of human cells for medical use for treating patients having a tumor and solid tumor

Cells for medical and clinical use; cell growth media for growing cells for medical and clinical use and cell growth stimulatory factors being synthetic cholesterol mainly for use in growing cell cultures; white blood cell and lymphocyte growth media for growing cells for medical and clinical use and stimulatory factors in the nature of culture media for cultivating human cells; white blood cells and lymphocytes for medical and clinical use; medicaments to help assist with the regeneration of ligament and tendon fibers and cell therapies and treatments containing cells, white blood cells and lymphocytes for medical and clinical use; medical reagents for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; medical reagents for solid tumor tissue digestion, white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation

Cells for scientific and research use; cell growth media for growing cells for scientific and research use; reagents for scientific and research use for tissue digestion, cell isolation, cell storage, cell population expansion and amplification, cell growth and cell stimulation; reagents for scientific and research use for white blood cell and lymphocyte isolation, cell storage, white blood cell and lymphocyte population expansion and amplification, and white blood cell and lymphocyte growth and stimulation

Providing a website featuring information in the field of the diagnosis and treatment of cancer; providing medical services for tissue digestion, cell isolation, cell population expansion and amplification, cell growth and stimulation, solid tumor tissue digestion, white blood cell and lymphocyte isolation, white blood cell and lymphocyte storage, white blood cell and lymphocyte expansion and amplification, and white blood cell and lymphocyte growth and stimulation; providing medical services for treating patients with tumors

Medical specimen apparatus in the nature of needles, tubing, glass slides, cups, and bags for collection of solid biological tissue samples and specimens, and for collection of solid biological tumor tissue samples, and isolation of cells therefrom and isolation and storage of cells therefrom, and isolation of white blood cells and lymphocytes therefrom, and isolation and storage of white blood cells therefrom

Medical and scientific research and development in the fields of tissue digestion, tumor tissue digestion, and cell isolation, storage, expansion and amplification, white blood cell and lymphocyte isolation, storage, expansion and amplification, reagents for cell population expansion or amplification, reagents for expansion and amplification of white blood cells and lymphocytes, cell growth and stimulatory factors, white blood cell and lymphocyte growth and stimulatory factors, tumors, white blood cells, lymphocytes, and medical apparatus for collection of solid biological tissue samples and specimens, and for collection of solid biological tumor tissue samples, and isolation of cells therefrom and isolation and storage of cells therefrom, and isolation of white blood cells and lymphocytes therefrom, and isolation and storage of white blood cells therefrom

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 10, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 10, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 29, 2024 EXRA
SOU EXTENSION 5 GRANTED
Aug 29, 2024 EX5G
SOU EXTENSION 5 FILED
Aug 29, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Aug 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 29, 2024 EXRA
SOU EXTENSION 4 GRANTED
Feb 28, 2024 EX4G
SOU EXTENSION 4 FILED
Feb 28, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 28, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2023 EXRA
SOU EXTENSION 3 GRANTED
Sep 1, 2023 EX3G
SOU EXTENSION 3 FILED
Sep 1, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 1, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 19, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 19, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 19, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 19, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 19, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2023 EXRA
SOU EXTENSION 2 GRANTED
Feb 13, 2023 EX2G
SOU EXTENSION 2 FILED
Feb 13, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 13, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 3, 2022 EXRA
SOU EXTENSION 1 GRANTED
Sep 1, 2022 EX1G
SOU EXTENSION 1 FILED
Sep 1, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 1, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 28, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 8, 2022 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2022 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 11, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 11, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 7, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 7, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 7, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 7, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 7, 2021 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 6, 2021 GNFN
FINAL REFUSAL E-MAILED
Dec 6, 2021 GNFR
FINAL REFUSAL WRITTEN
Dec 6, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 6, 2021 CNRT
ASSIGNED TO EXAMINER
May 6, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2021 NWOS
NEW APPLICATION ENTERED
Jan 15, 2021 NWAP